363 related articles for article (PubMed ID: 25047812)
1. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.
Okiyama N; Katz SI
J Autoimmun; 2014 Sep; 53():1-9. PubMed ID: 25047812
[TBL] [Abstract][Full Text] [Related]
2. Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice.
Shibaki A; Sato A; Vogel JC; Miyagawa F; Katz SI
J Invest Dermatol; 2004 Jul; 123(1):109-15. PubMed ID: 15191550
[TBL] [Abstract][Full Text] [Related]
3. IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression.
Stein S; Henze L; Poch T; Carambia A; Krech T; Preti M; Schuran FA; Reich M; Keitel V; Fiorotto R; Strazzabosco M; Fischer L; Li J; Müller LM; Wagner J; Gagliani N; Herkel J; Schwinge D; Schramm C
J Hepatol; 2021 Apr; 74(4):919-930. PubMed ID: 33197512
[TBL] [Abstract][Full Text] [Related]
4. Identification of CD3+CD4-CD8- T cells as potential regulatory cells in an experimental murine model of graft-versus-host skin disease (GVHD).
Miyagawa F; Okiyama N; Villarroel V; Katz SI
J Invest Dermatol; 2013 Nov; 133(11):2538-2545. PubMed ID: 23648548
[TBL] [Abstract][Full Text] [Related]
5. IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease.
Miyagawa F; Tagaya Y; Kim BS; Patel HJ; Ishida K; Ohteki T; Waldmann TA; Katz SI
J Immunol; 2008 Jul; 181(2):1109-19. PubMed ID: 18606663
[TBL] [Abstract][Full Text] [Related]
6. Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis.
Kim BS; Miyagawa F; Cho YH; Bennett CL; Clausen BE; Katz SI
J Invest Dermatol; 2009 Dec; 129(12):2805-17. PubMed ID: 19554018
[TBL] [Abstract][Full Text] [Related]
7. Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.
Ritprajak P; Hashiguchi M; Tsushima F; Chalermsarp N; Azuma M
J Immunol; 2010 May; 184(9):4918-25. PubMed ID: 20363965
[TBL] [Abstract][Full Text] [Related]
8. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality.
Saha A; Aoyama K; Taylor PA; Koehn BH; Veenstra RG; Panoskaltsis-Mortari A; Munn DH; Murphy WJ; Azuma M; Yagita H; Fife BT; Sayegh MH; Najafian N; Socie G; Ahmed R; Freeman GJ; Sharpe AH; Blazar BR
Blood; 2013 Oct; 122(17):3062-73. PubMed ID: 24030385
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 on mast cells suppresses effector CD8
Hirano T; Honda T; Kanameishi S; Honda Y; Egawa G; Kitoh A; Nakajima S; Otsuka A; Nomura T; Dainichi T; Yaguchi T; Inozume T; Kataoka TR; Tamada K; Kabashima K
J Allergy Clin Immunol; 2021 Aug; 148(2):563-573.e7. PubMed ID: 33581199
[TBL] [Abstract][Full Text] [Related]
10. CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease.
Villarroel VA; Okiyama N; Tsuji G; Linton JT; Katz SI
J Invest Dermatol; 2014 Jun; 134(6):1552-1560. PubMed ID: 24390137
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.
Tewalt EF; Cohen JN; Rouhani SJ; Guidi CJ; Qiao H; Fahl SP; Conaway MR; Bender TP; Tung KS; Vella AT; Adler AJ; Chen L; Engelhard VH
Blood; 2012 Dec; 120(24):4772-82. PubMed ID: 22993390
[TBL] [Abstract][Full Text] [Related]
12. The use of mouse models to better understand mechanisms of autoimmunity and tolerance.
Miyagawa F; Gutermuth J; Zhang H; Katz SI
J Autoimmun; 2010 Nov; 35(3):192-8. PubMed ID: 20655706
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells.
Ni X; Song Q; Cassady K; Deng R; Jin H; Zhang M; Dong H; Forman S; Martin PJ; Chen YZ; Wang J; Zeng D
J Clin Invest; 2017 May; 127(5):1960-1977. PubMed ID: 28414296
[TBL] [Abstract][Full Text] [Related]
14. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
[TBL] [Abstract][Full Text] [Related]
15. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
Keir ME; Freeman GJ; Sharpe AH
J Immunol; 2007 Oct; 179(8):5064-70. PubMed ID: 17911591
[TBL] [Abstract][Full Text] [Related]
16. Reactive glia promote development of CD103
Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.
Juchem KW; Sacirbegovic F; Zhang C; Sharpe AH; Russell K; McNiff JM; Demetris AJ; Shlomchik MJ; Shlomchik WD
J Immunol; 2018 Jan; 200(2):834-846. PubMed ID: 29212909
[TBL] [Abstract][Full Text] [Related]
18. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
Front Immunol; 2018; 9():1955. PubMed ID: 30214445
[No Abstract] [Full Text] [Related]
19. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
Martin-Orozco N; Wang YH; Yagita H; Dong C
J Immunol; 2006 Dec; 177(12):8291-5. PubMed ID: 17142723
[TBL] [Abstract][Full Text] [Related]
20. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
